SCHEMBL24425867

SCHEMBL24425867

C=C(C)CC/C=C/COC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
ALOX15 P16050 2/20 0.43
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
USP2 O75604 1/20 0.36
CYP3A4 P08684 1/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 2/20 0.34
PTPN1 P18031 1/20 0.33
TSHR P16473 1/20 0.31
PRKCA P17252 1/20 0.31
FFAR1 O14842 1/20 0.31
CYP19A1 P11511 1/20 0.31
RXRA P19793 1/20 0.31
PPARG P37231 1/20 0.31
OXER1 Q8TDS5 1/20 0.31
EPHX1 P07099 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10978359 0.83 TSHR (0.46) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL10978354 0.83 TSHR (0.46) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL31508640 0.83 ALDH1A1 (0.47) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL14296530 0.83 ALDH1A1 (0.47) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL13277587 0.82 PPARG (0.48) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL5385680 0.82 PPARG (0.48) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL5385674 0.82 PPARG (0.48) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL74779 0.80 ALDH1A1 (0.50) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL271027 0.80 ALDH1A1 (0.50) ALDH1A1ALOX15LMNAMAPTUSP2
SCHEMBL221749 0.80 ALDH1A1 (0.50) ALDH1A1ALOX15LMNAMAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11331656-B2 Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2022-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11331656-B2 Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis PPOX, CYBA, CYBB ALDH1A1 1395/4885ALOX15 18/4885LMNA 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.